P/O CRYOPRESERVED NO-SPIN HEPARG (8M CELLS/VIAL)

P/O 冷冻保存免旋转 HEPAG（8M 细胞/瓶）

• 批准号: 10022709
• 负责人: HAYLEE BACHMAN
• 金额: $ 10.04万
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-02-22 至 2019-04-21
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10022709
• 关键词: 3-Dimensional; Affect; Cells; Cellular Structures; Chemicals; Collaborations; Cryopreservation; Ensure; Hepatocyte; Human; Metabolic; Metabolic Activation; Metabolism; Morphology; National Institute of Environmental Health Sciences; Parents; Toxic effect; Vial device; biological systems; high throughput screening; screening

The purpose of this is to acquire primary human hepatocytes for chemical toxicity screening in 2D and/or 3D as part of a large scale collaboration between the US EPA and the NIEHS/DNTP, including but not limited to the Tox21 MOU.

其目的是获取原代人肝细胞，用于2D和/或3D化学毒性筛选，作为US EPA和NIEHS/DNTP之间大规模合作的一部分，包括但不限于Tox 21 MOU。